These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 7403440)
21. Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors. Scott AM; Geleick D; Rubira M; Clarke K; Nice EC; Smyth FE; Stockert E; Richards EC; Carr FJ; Harris WJ; Armour KL; Rood J; Kypridis A; Kronina V; Murphy R; Lee FT; Liu Z; Kitamura K; Ritter G; Laughton K; Hoffman E; Burgess AW; Old LJ Cancer Res; 2000 Jun; 60(12):3254-61. PubMed ID: 10866319 [TBL] [Abstract][Full Text] [Related]
22. Virologic and immunologic properties and response to daunomycin and adriamycin of a non-regressing mouse tumor derived from MSV-induced sarcoma. Giuliani F; Casazza AM; Di Marco A Biomedicine; 1974 Nov; 21(11):435-9. PubMed ID: 4377230 [No Abstract] [Full Text] [Related]
23. Kinetically directed combination therapy with adriamycin and x-irradiation in a mammary tumor model. Braunschweiger PG; Schenken LL; Schiffer LM Int J Radiat Oncol Biol Phys; 1981 Jun; 7(6):747-53. PubMed ID: 7287535 [No Abstract] [Full Text] [Related]
24. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors. Sirotnak FM; Otter GM; Schmid FA Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192 [TBL] [Abstract][Full Text] [Related]
25. [Differential effect of fractionated irradiation and the administration of 5-fluorouracil on a mammary tumor in the BALB/c/Cnb mouse]. Maisin H; Anckaert MA; De Coster B C R Seances Soc Biol Fil; 1983; 177(1):116-9. PubMed ID: 6221779 [No Abstract] [Full Text] [Related]
27. In vivo tumor response to single and multiple exposures of adriamycin. Siemann DW; Sutherland RM Eur J Cancer (1965); 1980 Nov; 16(11):1433-40. PubMed ID: 7227420 [No Abstract] [Full Text] [Related]
28. The effects of misonidazole during continuous low dose rate irradiation. Fu KK; Hurst S; Begg AC; Brown JM Cancer Clin Trials; 1980; 3(3):257-65. PubMed ID: 7438323 [TBL] [Abstract][Full Text] [Related]
29. Radiation, adriamycin, and skin reactions: effects of radiation and drug fractionation, hyperthermia, and tetracycline. Redpath JL; Zabilansky E; Colman M Radiat Res; 1981 Jun; 86(3):459-66. PubMed ID: 7244122 [No Abstract] [Full Text] [Related]
30. MTA (LY231514) in combination treatment regimens using human tumor xenografts and the EMT-6 murine mammary carcinoma. Teicher BA; Alvarez E; Liu P; Lu K; Menon K; Dempsey J; Schultz RM Semin Oncol; 1999 Apr; 26(2 Suppl 6):55-62. PubMed ID: 10598556 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity. Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317 [TBL] [Abstract][Full Text] [Related]
32. Sub-additive effect of the combination of radiation and cisplatin in cultured murine and human cell lines. Gorodetsky R; Mou X; Pfeffer MR; Peretz T; Levy-Agababa F; Vexler AM Isr J Med Sci; 1995; 31(2-3):95-100. PubMed ID: 7744601 [TBL] [Abstract][Full Text] [Related]
33. Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model. Harrington KJ; Rowlinson-Busza G; Syrigos KN; Vile RG; Uster PS; Peters AM; Stewart JS Clin Cancer Res; 2000 Dec; 6(12):4939-49. PubMed ID: 11156255 [TBL] [Abstract][Full Text] [Related]
34. Drug- and radiation-induced resistance in a human neurogenic sarcoma xenografted in nude mice. Budach W; Budach V; Scheulen ME; Stuschke M; Chaborski P Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S169-73. PubMed ID: 8453692 [TBL] [Abstract][Full Text] [Related]
35. Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel. Milas L; Hunter NR; Mason KA; Kurdoglu B; Peters LJ Cancer Res; 1994 Jul; 54(13):3506-10. PubMed ID: 7912167 [TBL] [Abstract][Full Text] [Related]
36. Crucial role for interferon gamma in the synergism between tumor vasculature-targeted tumor necrosis factor alpha (NGR-TNF) and doxorubicin. Sacchi A; Gasparri A; Curnis F; Bellone M; Corti A Cancer Res; 2004 Oct; 64(19):7150-5. PubMed ID: 15466213 [TBL] [Abstract][Full Text] [Related]
37. Distribution of adriamycin in mice under conditions of local hyperthermia which improve systemic drug therapy. Magin RL; Cysyk RL; Litterst CL Cancer Treat Rep; 1980; 64(2-3):203-10. PubMed ID: 7407753 [TBL] [Abstract][Full Text] [Related]
38. Cyclic radiation-induced variations in cellular radiosensitivity in a mouse mammary tumor. Rockwell S; Kallman RF Radiat Res; 1974 Jan; 57(1):132-47. PubMed ID: 10874932 [No Abstract] [Full Text] [Related]
39. Acute in vivo resistance in high-dose therapy. Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940 [TBL] [Abstract][Full Text] [Related]
40. Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells. Croci S; Nicoletti G; Landuzzi L; Palladini A; Chiarini F; Nanni P; Lollini PL; De Giovanni C Oncol Rep; 2007 Aug; 18(2):451-6. PubMed ID: 17611670 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]